Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes
Open Access
- 1 February 1999
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 58 (2) , 118-121
- https://doi.org/10.1136/ard.58.2.118
Abstract
OBJECTIVES The active form of vitamin D3, 1α,25 dihydroxyvitamin D3(1,25D3), through its interaction with vitamin D receptors (VDR), is reported to effect a variety of anabolic and catabolic events, especially in bone and cartilage tissues. As cartilage degradation and tissue remodelling are characteristic features of the rheumatoid lesion, the distribution and expression of VDR at sites of cartilage erosion was examined. METHODS Immunolocalisation techniques using a rat monoclonal antibody to VDR and an alkaline phosphatase conjugated avidin/biotin detection system were used to examine VDR in 18 specimens of cartilage-pannus junction, 10 specimens of rheumatoid synovium or cartilage tissue, and four primary cultures of adherent rheumatoid synovial cells (RSC). For comparison, VDR expression was examined in 10 specimens of normal, healthy age matched articular cartilage. RESULTS VDR was demonstrated in 15 of 18 cartilage-pannus junctions either at the interface (8 of 18), within the pannus tissue (12 of 18), and by chondrocytes often close to the erosive lesion (10 of 18). All the rheumatoid synovial tissue and 5 of 10 cartilage specimens showed cells with positive staining, but the extent of this was variable. Negligible VDR staining was observed for normal cartilage. Primary cultures of RSC also showed variability in both the numbers and proportions of macrophages or synovial fibroblasts stained for VDR (range 10–50%), this being more common in cultures with a high proportion of macrophages. CONCLUSIONS VDR expression has been demonstrated by most specimens of cartilage-pannus junction; was associated with various cell types, including chondrocytes, but not exclusively with CD68+ macrophages. The focal nature of VDR expression within the rheumatoid lesion suggests a contributory role for 1α,25D3 in the pathophysiological processes of rheumatoid arthritis.Keywords
This publication has 14 references indexed in Scilit:
- Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathwayJournal of Cellular Biochemistry, 1997
- Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritisLife Sciences, 1997
- Regulation of rat interstitial collagenase gene expression in growth cartilage and chondrocytes by vitamin D3, interleukin-1β, and okadaic acidJournal of Cellular Biochemistry, 1996
- Vitamin D Metabolites Regulate Matrix Vesicle Metalloproteinase Content in a Cell Maturation-Dependent MannerCalcified Tissue International, 1996
- Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.Annals of the Rheumatic Diseases, 1995
- 1,25-dihydroxyvitamin D3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes.Journal of Biological Chemistry, 1994
- Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivoRheumatology International, 1993
- Immunological properties of vitamin D analogues and metabolitesBiochemical Pharmacology, 1992
- Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin d in patients with inflammatory arthritisJournal of Bone and Mineral Research, 1991
- Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases.Annals of the Rheumatic Diseases, 1989